Andres J Yarur (Andres Yarur, A J Yarur)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Patients With Inflammatory Bowel Disease

Top Venues

Advances in therapy

The American journal of gastroenterology

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Andres J Yarur, Gerassimos J Mantzaris, Song Wang, Shashi Adsul, Pravin Kamble, Erin Cook, Gautam Sajeev, Annie Guerin, Brian Bressler
Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn's Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study. Advances in therapy 41 (6) (2024)
Andres J Yarur, Gerassimos J Mantzaris, Song Wang, Shashi Adsul, Pravin Kamble, Erin Cook, Gautam Sajeev, Annie Guerin, Brian Bressler
Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn's Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study. Advances in therapy 41 (6) (2024)
Andres J Yarur, Ryan C Ungaro, Katherine Huang, Wenfei Wang, Priya Sasankan, Mir Zulqarnain, Amanda M Johnson, Geoffrey Bader, Carl Kay, Nicholas Costable, David Dulaney, Marc Fenster, Poonam Beniwal-Patel, Gaurav Syal, Anish Patel, Edward Loftus, Joel Pekow, Benjamin Cohen, Parakkal Deepak
Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium. Inflammatory bowel diseases (2024)
Andres J Yarur, Gerassimos J Mantzaris, Song Wang, Shashi Adsul, Pravin Kamble, Erin Cook, Gautam Sajeev, Annie Guerin, Brian Bressler
Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn's Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study. Advances in therapy (2024)
Kelly Issokson, Dale Young Lee, Andres J Yarur, James D Lewis, David L Suskind
The Role of Diet in Inflammatory Bowel Disease Onset, Disease Management, and Surgical Optimization. The American journal of gastroenterology (2024)
Andres J Yarur, Gerassimos J Mantzaris, Song Wang, Shashi Adsul, Pravin Kamble, Erin Cook, Gautam Sajeev, Annie Guerin, Brian Bressler
Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn's Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study. Advances in therapy 41 (6) (2024)
Andres J Yarur, Ryan C Ungaro, Katherine Huang, Wenfei Wang, Priya Sasankan, Mir Zulqarnain, Amanda M Johnson, Geoffrey Bader, Carl Kay, Nicholas Costable, David Dulaney, Marc Fenster, Poonam Beniwal-Patel, Gaurav Syal, Anish Patel, Edward Loftus, Joel Pekow, Benjamin Cohen, Parakkal Deepak
Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium. Inflammatory bowel diseases (2024)
Andres J Yarur, Gerassimos J Mantzaris, Song Wang, Shashi Adsul, Pravin Kamble, Erin Cook, Gautam Sajeev, Annie Guerin, Brian Bressler
Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn's Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study. Advances in therapy 41 (6) (2024)
Paulina Núñez, Rodrigo Quera, Andres J Yarur
Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases. Drugs (2023)
Paulina Núñez, Rodrigo Quera, Andres J Yarur
Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases. Drugs 83 (4) (2023)
Paulina Núñez, Rodrigo Quera, Andres J Yarur
Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases. Drugs 83 (4) (2023)
Andres J Yarur
Response to Bourgonje and Mian. The American journal of gastroenterology 118 (12) (2023)
Andres J Yarur, Maria T Abreu, Parakkal Deepak, Poonam Beniwal-Patel, Konstantinos Papamichail, Byron Vaughn, Alexandra Bruss, Shaina Sekhri, Andrea Moosreiner, Phillip Gu, William Kennedy, Marla Dubinsky, Adam Cheifetz, Gil Y Melmed
PATIENTS WITH INFLAMMATORY BOWEL DISEASES AND HIGHER VISCERAL ADIPOSE TISSUE BURDEN MAY BENEFIT FROM HIGHER INFLIXIMAB CONCENTRATIONS TO ACHIEVE REMISSION. The American journal of gastroenterology (2023)
Sanket Patel, Andres J Yarur
A Review of Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Receiving Combination Therapy. Journal of clinical medicine 12 (20) (2023)
Paulina Núñez, Rodrigo Quera, Andres J Yarur
Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases. Drugs (2023)
Paulina Núñez, Rodrigo Quera, Andres J Yarur
Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases. Drugs 83 (4) (2023)
Mir Zulqarnain, Parakkal Deepak, Andres J Yarur
Therapeutic Drug Monitoring in Perianal Fistulizing Crohn's Disease. Journal of clinical medicine 11 (7) (2022)
Andres J Yarur, Parakkal Deepak, Niels Vande Casteele, Robert Battat, Anjali Jain, Lauren Okada, Mark Osterman, Miguel Regueiro
Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases. Digestive diseases and sciences 66 (10) (2020)
Andres J Yarur, Alexandra Bruss, Snehal Naik, Poonam Beniwal-Patel, Caroline Fox, Anjali Jain, Brandon Berens, Amir Patel, Ryan Ungaro, Bayda Bahur, Marla Dubinsky, Daniel J Stein
Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases. Digestive diseases and sciences 64 (6) (2019)
Andres J Yarur, V Kanagala, D J Stein, F Czul, M A Quintero, D Agrawal, A Patel, K Best, C Fox, K Idstein, M T Abreu
Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease. Alimentary pharmacology & therapeutics 45 (7) (2017)